Results 201 to 210 of about 1,719,335 (360)
In vivo SALI therapy is achieved by scavenging intracellular ROS levels, downregulating inflammatory factors expression levels, inducing macrophage M2 directional polarization, and activating Keap1/Nrf‐2/HO‐1 pathway to reprogram redox homeostasis, induce cellular autophagy, reduce systemic inflammation, and promote liver tissue repair. Abstract Sepsis
Tao Qin+21 more
wiley +1 more source
Ensifentrine: A Novel Option for Maintenance of Chronic Obstructive Pulmonary Disease. [PDF]
Hitt EM, Powell AJ.
europepmc +1 more source
A highly efficient extracorporeal device for treating bacteremia is developed by integrating microfluidic bacterial margination and engineered cell‐depleted thrombi strategically constructed in the device. The rodent models, severely infected with antibiotic‐resistant bacteria, recover from bacteremia after two subsequent extracorporeal blood ...
Bong Hwan Jang+4 more
wiley +1 more source
Phenotypes of Exacerbations in Chronic Obstructive Pulmonary Disease. [PDF]
Nisip Avram LC+5 more
europepmc +1 more source
Effects of surgical closure of ventricular septal defects upon pulmonary vascular disease. [PDF]
K A Hallidie-Smith+4 more
openalex +1 more source
Recent Advances in mRNA Delivery Systems for Cancer Therapy
This review systematically investigates the applications of mRNA therapy in cancer treatment, with particular emphasis on nonviral delivery systems, targeting strategies, stimulus‐responsive systems, and local delivery methods. Concluding with a meticulous evaluation, the review sheds light on the prevailing challenges while illuminating promising ...
Zheng Zhang+9 more
wiley +1 more source
Determinants of poor chronic obstructive pulmonary disease control. [PDF]
Jarab AS+7 more
europepmc +1 more source
THE USE OF RADIOACTIVE CARBON DIOXIDE TO MEASURE REGIONAL BLOOD FLOW IN THE LUNGS OF PATIENTS WITH PULMONARY DISEASE [PDF]
John B. West+2 more
openalex +1 more source
Irisin is a crucial plasma biomarker and promising therapeutic target that reflects disease severity, pulmonary vascular remodeling status and clinical outcome in patients with pulmonary arterial hypertension (PAH). As a novel protective factor, irisin is downregulated in PAH. By ubiquitination, irisin promotes Enolase 1 degradation and suppresses cell
Na Sun+15 more
wiley +1 more source
Effects of pulmonary telerehabilitation in patients with chronic obstructive pulmonary disease. [PDF]
Qi J, Cai Q, Zhang W, Gu Y.
europepmc +1 more source